InVitro Capital Fund I LP
Open: first sale Aug 2024, per Form D (fund age approximates vintage)
- Vintage
- 2024
- Fund size
- $3.55M to $50M (Form D)
- Stages
- Seed, Growth
- Sectors
- Healthtech, Fintech, HR and future of work
- Regions
- Not stated
01 · Thesis
InVitro Capital builds and funds AI companies from idea to exit, targeting fragmented, labor-intensive markets in healthcare, HealthTech, FinTech, AdTech and HR. It acquires, builds and scales portfolio companies with hands-on operational support and long-term ownership.Inferred from the firm's website
02 · Initial check
$36K to $833K (estimated from fund size)
Estimated from Form D: $3.55M sold of a $50M target
03 · Who to approach
Named on this fund's Form D
- Amir Barsoum
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideInVitro Capital's first fund is reported to have a TVPI of 15.9x for its 2021 fund. Mario Karras played a pivotal role in raising the inaugural fund.
InVitro Capital’s first fund has a TVPI of 15.9x for their 2021 fund
https://invitrocapital.com/newsinsights/thought-leadership/venture-builders-the-next-generation-of-private-market-investments/Firm-wideInVitro Capital is a holding company that acquires, builds, and scales AI companies transforming healthcare, with portfolio companies in HealthTech, FinTech, and HR.
We acquire, build, and scale AI companies transforming healthcare.
https://invitrocapital.com/
06 · Sources
Last verified: Oct 28, 2026